152 related articles for article (PubMed ID: 11535113)
1. Dopamine receptor polymorphisms and drug response in schizophrenia.
Scharfetter J
Pharmacogenomics; 2001 Aug; 2(3):251-61. PubMed ID: 11535113
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update.
Scharfetter J
Pharmacogenomics; 2004 Sep; 5(6):691-8. PubMed ID: 15335289
[TBL] [Abstract][Full Text] [Related]
3. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
4. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems.
Dollfus S; Campion D; Vasse T; Preterre P; Laurent C; d'Amato T; Thibaut F; Mallet J; Petit M
Biol Psychiatry; 1996 Sep; 40(5):419-21. PubMed ID: 8874845
[No Abstract] [Full Text] [Related]
5. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics and treatment response in schizophrenia].
Moulier V; Januel D
Encephale; 2007 Dec; 33(6):954-64. PubMed ID: 18789788
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
Jardemark K; Wadenberg ML; Grillner P; Svensson TH
Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059
[TBL] [Abstract][Full Text] [Related]
8. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
9. Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus.
Nanko S; Fukuda R; Hattori M; Sasaki T; Dai XY; Yamaguchi K; Kazamatsuri H
Am J Med Genet; 1994 Sep; 54(3):264-7. PubMed ID: 7810586
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in dopamine receptors: what do they tell us?
Wong AH; Buckle CE; Van Tol HH
Eur J Pharmacol; 2000 Dec; 410(2-3):183-203. PubMed ID: 11134669
[TBL] [Abstract][Full Text] [Related]
13. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
[TBL] [Abstract][Full Text] [Related]
14. Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: probable effects of family history of schizophrenia?
Nimgaonkar VL; Zhang XR; Caldwell JG; Ganguli R; Chakravarti A
Am J Med Genet; 1993 Dec; 48(4):214-7. PubMed ID: 8135304
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
[TBL] [Abstract][Full Text] [Related]
16. [Receptor polymorphism and response to treatment in schizophrenia].
Szekeres G; Janka Z
Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and schizophrenia.
Foster A; Miller DD; Buckley PF
Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
[TBL] [Abstract][Full Text] [Related]
18. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia.
Shaikh S; Gill M; Owen M; Asherson P; McGuffin P; Nanko S; Murray RM; Collier DA
Am J Med Genet; 1994 Mar; 54(1):8-11. PubMed ID: 8178839
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics and tailored drug treatment in schizophrenia].
Andreassen OA; Steen VM
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
